Galectin-1

Galectin-1

Galectin-1 Molekülinformation

Molecule Name
Galectin-1
Molekülalias
LGALS1,GAL1,GBP,Galectin-1,DKFZp686E23103
Drug Development Progress
Anzahl der klinischen Arzneimittel1
Anzahl der inverkehr gebrachten Arzneimittel1
Höchste Forschungs- und EntwicklungsphaseApproved
Target-Alias
Epididymis Secretory Sperm Binding Protein,Lectin, Galactoside-Binding, Soluble, 1,Beta-Galactoside-Binding Lectin L-14-I,14 KDa Laminin-Binding Protein,S-Lac Lectin 1,14 KDa Lectin,Galaptin,HLBP14,Gal-1,HPL,Beta-Galactoside-Binding Protein 14kDa,Lectin Galactoside-Binding Soluble 1,GAL1,GBP,Galectin 1,Putative MAPK-activating protein PM12,Galectin-1,HBL,LGALS1,Lactose-binding lectin 1
Molekülhintergrund
Galectin-1 (Gal-1), a member of the β-galactoside-binding animal lectin family, has a wide range of biological activities, which makes it an attractive target for medical applications. Gal-1 is ubiquitously but differentially expressed in normal and pathological animal tissues, and a variety of biological activities, including modulation of innate and adaptive immune responses, malignant progression of tumor cells, etc.

Galectin-1 Produktliste

Species
  • Human(1)
Tag
  • Tag Free(1)
Host
  • E. coli(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • Yes(1)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
Galectin-1
Human Galectin-1 / LGALS1 Protein, Tag Free, low endotoxin (MALS & BLI verified)
Human
E. coli
MALSSDS-PAGE
SPRBLI

$340.00

100ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
OlitigaltinGB-0139; TD-139Phase 2 ClinicalLund University Foundation, The University Of Edinburgh
Coronavirus Disease 2019 (COVID-19); Idiopathic Pulmonary Fibrosis
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
OcriplasminA-01016; THR-409ApprovedThrombogenicsJetrea, JejetreaUnited StatesVitreomacular AdhesionThrombogenics Inc2012-10-17
Arterial Occlusive Diseases; Diabetic macular oedema; Diabetic Retinopathy; Disease Progression; Eye Diseases; Macular Degeneration; Retinal Diseases; Retinal Vein Occlusion; Stroke; Uveitis; Venous Thrombosis; Vitreomacular Adhesion; Vitreous Detachment
Details
Customer Reviews
  • L***h2021-12-13
    Dear Sir or Madam, I had an overall good service from Acro Biosystems. Shipment was fast and product quality was good. Got the protocol for QC after asking the customer service. Protocol for QC was easy to understand and repeat. Easy way to download the Certificate of Analysis via the printed QR code on product vials. Customer service answered very fast and was very friendly. QC of Human Galectin-1 protein vs. biotinylated human CD45 protein (CD5-H82E7) was fine.